Optical coherence tomography image based eye disease detection using deep convolutional neural network

Evaluating Retinal Disease Diagnosis with an Interpretable Lightweight CNN Model Resistant to Adversarial Attacks

Optical Coherence Tomography (OCT) is an imperative symptomatic tool empowering the diagnosis of retinal diseases and anomalies. The manual decision towards those anomalies by specialists is the norm, but its labor-intensive nature calls for more proficient strategies. Consequently, the study recommends employing a Convolutional Neural Network (CNN) for the classification of OCT images derived from the OCT dataset into distinct categories, including Choroidal NeoVascularization (CNV), Diabetic Macular Edema (DME), Drusen, and Normal. The average k-fold (k = 10) training accuracy, test accuracy, validation accuracy, training loss, test loss, and validation loss values of the proposed model are 96.33%, 94.29%, 94.12%, 0.1073, 0.2002, and 0.1927, respectively. Fast Gradient Sign Method (FGSM) is employed to introduce non-random noise aligned with the cost function's data gradient, with varying epsilon values scaling the noise, and the model correctly handles all noise levels below 0.1 epsilon. Explainable AI algorithms: Local Interpretable Model-Agnostic Explanations (LIME) and SHapley Additive exPlanations (SHAP) are utilized to provide human interpretable explanations approximating the behaviour of the model within the region of a particular retinal image. Additionally, two supplementary datasets, namely, COVID-19 and Kidney Stone, are assimilated to enhance the model's robustness and versatility, resulting in a level of precision comparable to state-of-the-art methodologies. Incorporating a lightweight CNN model with 983,716 parameters, 2.37×108 floating point operations per second (FLOPs) and leveraging explainable AI strategies, this study contributes to efficient OCT-based diagnosis, underscores its potential in advancing medical diagnostics, and offers assistance in the Internet-of-Medical-Things.

Neural Networks for the Detection of COVID-19 and Other Diseases: Prospects and Challenges

Artificial neural networks (ANNs) ability to learn, correct errors, and transform a large amount of raw data into beneficial medical decisions for treatment and care has increased in popularity for enhanced patient safety and quality of care. Therefore, this paper reviews the critical role of ANNs in providing valuable insights for patients' healthcare decisions and efficient disease diagnosis. We study different types of ANNs in the existing literature that advance ANNs' adaptation for complex applications. Specifically, we investigate ANNs' advances for predicting viral, cancer, skin, and COVID-19 diseases. Furthermore, we propose a deep convolutional neural network (CNN) model called ConXNet, based on chest radiography images, to improve the detection accuracy of COVID-19 disease. ConXNet is trained and tested using a chest radiography image dataset obtained from Kaggle, achieving more than 97% accuracy and 98% precision, which is better than other existing state-of-the-art models, such as DeTraC, U-Net, COVID MTNet, and COVID-Net, having 93.1%, 94.10%, 84.76%, and 90% accuracy and 94%, 95%, 85%, and 92% precision, respectively. The results show that the ConXNet model performed significantly well for a relatively large dataset compared with the aforementioned models. Moreover, the ConXNet model reduces the time complexity by using dropout layers and batch normalization techniques. Finally, we highlight future research directions and challenges, such as the complexity of the algorithms, insufficient available data, privacy and security, and integration of biosensing with ANNs. These research directions require considerable attention for improving the scope of ANNs for medical diagnostic and treatment applications.